Phathom Pharmaceuticals (PHAT) Research & Development: 2022-2025
Historic Research & Development for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $7.0 million.
- Phathom Pharmaceuticals' Research & Development fell 19.16% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.9 million, marking a year-over-year decrease of 12.91%. This contributed to the annual value of $34.1 million for FY2024, which is 31.70% down from last year.
- As of Q3 2025, Phathom Pharmaceuticals' Research & Development stood at $7.0 million, which was down 22.58% from $9.1 million recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Research & Development ranged from a high of $19.0 million in Q3 2022 and a low of $7.0 million during Q3 2025.
- Its 3-year average for Research & Development is $9.9 million, with a median of $9.2 million in 2025.
- Per our database at Business Quant, Phathom Pharmaceuticals' Research & Development crashed by 42.21% in 2024 and then grew by 23.05% in 2025.
- Over the past 4 years, Phathom Pharmaceuticals' Research & Development (Quarterly) stood at $15.9 million in 2022, then dropped by 16.00% to $13.4 million in 2023, then slumped by 35.92% to $8.6 million in 2024, then dropped by 19.16% to $7.0 million in 2025.
- Its last three reported values are $7.0 million in Q3 2025, $9.1 million for Q2 2025, and $9.2 million during Q1 2025.